Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Tango Therapeutics Inc shares valued at $7,712,760 were sold by Third Rock Ventures IV, L.P. on Aug 19 ’25. At $7.01 per share, Third Rock Ventures IV, L.P. sold 1,100,000 shares. The insider’s holdings dropped to 15,759,075 shares worth approximately $110.47 million following the completion of this transaction.
Also, Third Rock Ventures IV, L.P. purchased 1,100,000 shares, netting a total of over 7,656,000 in proceeds.
Before that, Barry Douglas had sold 2,774 shares from its account. In a trade valued at $8,289, the General Counsel traded Tango Therapeutics Inc shares for $2.99 each. Upon closing the transaction, the insider’s holdings decreased to 2,774 shares, worth approximately $0.48 million.
As published in their initiating research note from Piper Sandler on August 19, 2025, Tango Therapeutics Inc [TNGX] has been an Overweight and the price target has been revised to $11. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid July. As of April 04, 2024, Cantor Fitzgerald has initiated its “an Overweight” rating for TNGX. Earlier on February 12, 2024, Piper Sandler initiated its rating. Their recommendation was “an Overweight” for TNGX stock.
Analyzing TNGX Stock Performance
On last trading session, Tango Therapeutics Inc [NASDAQ: TNGX] rose 3.85% to $7.01. The stock’s lowest price that day was $6.6, but it reached a high of $7.04 in the same session. During the last five days, there has been a surge of approximately 1.30%. Over the course of the year, Tango Therapeutics Inc shares have dropped approximately -34.36%. Shares of the company reached a 52-week high of $7.42 on 08/19/25 and a 52-week low of $1.03 on 05/08/25.
Support And Resistance Levels for Tango Therapeutics Inc (TNGX)
According to the 24-hour chart, there is a support level at 6.73, which, if violated, would cause prices to drop to 6.44. In the upper region, resistance lies at 7.17. The next price resistance is at 7.32. RSI (Relative Strength Index) is 58.86 on the 14-day chart, showing neutral technical sentiment.
Is Tango Therapeutics Inc subject to short interest?
Stocks of Tango Therapeutics Inc saw a sharp rise in short interest on 2025-07-31 jumping by 1.28 million shares to 22.48 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 21.19 million shares. A jump of 5.71% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.9 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.9.
Which companies own the most shares of Tango Therapeutics Inc (TNGX)?
In terms of Tango Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 13 in the next 12 months, up nearly 92.59% from the previous closing price of $6.75. Analysts anticipate Tango Therapeutics Inc stock to reach 18 by 2025, with the lowest price target being 13. In spite of this, 3 analysts ranked Tango Therapeutics Inc stock as Buy at the end of 2025. On December 08, 2023, B. Riley Securities assigned a price target of “a Buy” to the stock and initiated coverage with a $16.
